Contact Us | Print Page | Sign In | Register
News & Press: CMSC Industry News for MS (INforMS)

CMSC INforMS: A Letter from Lemtrada Regarding its Home Phlebotomy Partner, EMSI

Saturday, July 11, 2020   (0 Comments)
Posted by: Rachelle Ramirez
Share |

Good Day Lemtrada Patient –

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business.  Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. 

Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests.  We will be sure to communicate these alternatives to you as soon as possible.  Please be on the lookout for future communication from Sanofi Genzyme on this topic.

If you have any questions related to this announcement, please:
Contact your healthcare provider
Contact your One to One Nurse at 1-855-557-2483

We are very sorry for this disruption. 

Please see full Prescribing Information/Medication Guide, including serious side effects.

Sincerely,

Sanofi Genzyme



The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org